Journal profile · PHARMACOLOGY & PHARMACY
Journal of Pharmacy Practice
ISSN 0897-1900 · eISSN 1531-1937 · SAGE
Journal of Pharmacy Practice: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1 (journal website); hybrid open access; APC about USD 4,150; review about 162 days (submission to acceptance, publisher); acceptance rate 11.8% (journal website); 69 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Journal of Pharmacy Practice is published by SAGE and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pharmaceutical Practices and Patient Outcomes, Medication Adherence and Compliance and Pharmaceutical studies and practices, together about 33.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Pharmacy Practice (JPP) is a peer-reviewed journal that was established in 1988 and is published 6 times per year. The journal is read and cited both nationally and internationally. The journal is indexed by MEDLINE, EMBASE/Excerpta Medica, and Scopus, and many other indexing services. The journal offers practicing pharmacists in-depth useful … | View full journal description This journal is a member of the Committee on Publication Ethics (COPE).
From the journal's Aims & Scope
Research area (LetPub): PHARMACOLOGY & PHARMACY
Editor-in-chief Henry CohenPublisher website
Editorial board by country: none in mainland China; most named United States 65, United Kingdom 2, Saudi Arabia 1 (68 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pharmaceutical Practices and Patient OutcomesMedicine20.5%
- Medication Adherence and ComplianceMedicine6.7%
- Pharmaceutical studies and practicesMedicine6%
- Antibiotics Pharmacokinetics and EfficacyMedicine5.2%
- Atrial Fibrillation Management and OutcomesMedicine5.1%
- Venous Thromboembolism Diagnosis and ManagementMedicine4.8%
- Antibiotic Use and ResistanceImmunology and Microbiology4.2%
- Intensive Care Unit Cognitive DisordersMedicine3.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbasePublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 1Publisher website ·
- 5-year impact factor (publisher)
- 1.3Publisher website ·
- CiteScore 2026-06
- 3.5LetPub ·
- SJR 2026-06
- 0.41LetPub ·
- SNIP 2026-06
- 0.64LetPub ·
- h-index
- 54OpenAlex ·
- i10-index
- 672OpenAlex ·
- 2-year mean citedness
- 1.32OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 6.17%LetPub ·
Volume
- Articles per year
- 67LetPub ·
- Articles per year (publisher)
- 3Publisher website ·
Articles by year OpenAlex count · 3,104 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 52 | 15 | 7 |
| 2025 | 69 | 13 | 66 |
| 2024 | 107 | 36 | 227 |
| 2023 | 81 | 23 | 324 |
| 2022 | 199 | 36 | 978 |
| 2021 | 183 | 25 | 1,429 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
162 dayssubmission to acceptance
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Acceptance rate (publisher)
- 11.8%Publisher website ·
- Submission to first decision
- 11 daysPublisher website ·
- Submission to acceptance
- 162 daysPublisher website ·
- Acceptance to publication
- 13 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,150 / GBP 3,043 | — | — | |
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
Other charges and waivers (author guidelines)
- Other fees
- 800
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted17
- adverse drug event case reportsAdverse Drug Event Case Reports a. Abstract (250 word limit) b. Keywords (5 keywords limit) c. References (50 limit) d. Table Limit (2) e. Figure Limit (3) f. W…Length not stated
- biomedical communications or informatics reviewsBiomedical Communications or Informatics Reviews a. No Abstract b. Keywords (5 keywords limit) c. References (10 limit) d. Table and Figure Limit (6 to 15 combi…Length not stated
- case reportPlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Please note that figure and table captions do not count to…Length not stated
- case reports or case studiesCase Reports or Case Studies a. Abstract (250 word limit) b. Keywords (5 keywords limit) c. References (50 limit) d. Table Limit (2) e. Figure Limit (3) f. Word…Length not stated
- case studyPlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Please note that figure and table captions do not count to…Length not stated
- commentaryPlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Please note that figure and table captions do not count to…Length not stated
- continuing education articlesContinuing Education Articles a. Abstract (250 word limit) b. Keywords (5 keywords limit) c. Goals and Objectives (7 limit) d. References (150 limit) e. Table a…Length not stated
- drug or therapeutic review articlesDrug or Therapeutic Review Articles a. Abstract (250 word limit) b. Keywords (5 keywords limit) c. References (150 limit) d. Table and Figure Limit (6 to 15 com…Length not stated
- editorialPlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Please note that figure and table captions do not count to…Length not stated
- editorial or commentaryEditorial or Commentary a. Abstract (150 word limit) b. Keywords (5 keywords limit) c. References (20 limit) d. Table Limit (3; for Commentary only) e. Figure L…Length not stated
- letters to the editorPlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Please note that figure and table captions do not count to…Length not stated
- pharmacy experiential educationPharmacy Experiential Education a. Abstract (250 word limit) b. Keywords (5 keywords limit) c. References (100 limit) d. Table and Figure Limit (3 to 7 combined…Length not stated
- pharmacy practice review articlesPharmacy Practice Review Articles a. Abstract (250 word limit) b. Keywords (5 keywords limit) c. References (100 limit) d. Table and Figure Limit (6 to 15 combi…Length not stated
- research reportPlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Please note that figure and table captions do not count to…Length not stated
- research reportsResearch Reports a. Structured Abstract (250 word limit; to include Background, Objective, Methods, Results, Conclusion) b. Keywords (5 keywords limit) c. Refer…Length not stated
- reviewPlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Please note that figure and table captions do not count to…Length not stated
- review articlePlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Please note that figure and table captions do not count to…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Data availability, Publication ethics, Open access, Peer review, Plagiarism, Preprints, Trial registration / reporting guidelines
- AI use Evaluation of ChatGPT as a Tool for Answering Clinical Questions in Pharmacy Practice
Faria Munir PharmD, MS, BCPS Anna Gehres PharmD, BCACP David Wai PharmD, MS, BCPS Leah Song PharmD
Source ↗Publisher website ·- Authorship Author contributions
You will be asked to list the contribution of each author as part of the submission process. Please include the Author Contributions heading within your submission after the Acknowledgements section. The information you give on submission will then show under the Author Contributions heading later at the proofing stage.
Source ↗Publisher website ·- Data availability Data availability
The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…
Source ↗Publisher website ·- Publication ethics Ethical considerations
Member of COPE Model summary
Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…
Source ↗Publisher website ·- Open access Publishing fees and open access
There are no fees payable to submit or publish in this journal. Figures submitted in color will be published in color in the online version of the journal at no cost. If you wish to have color figures in the printed version, the following fees apply: $800 for the first figure and $200 for each additional figure Optional open access publishing is available for a fee via the Sage Choice program, and…
Source ↗Publisher website ·- Peer review Peer review policy
Double anonymized peer review Model summary
The following summary describes the peer review process for this journal: Identity transparency: Double-anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…
Source ↗Publisher website ·- Plagiarism Plagiarism
The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.
Source ↗Publisher website ·- Preprints Preprints
The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical trial registration
The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- SAGE
- ISSN
- 0897-1900
- Electronic ISSN
- 1531-1937
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Pharmacy Practice
What CAS zone is Journal of Pharmacy Practice in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Pharmacy Practice is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Pharmacy Practice?
The journal's website gives an impact factor of 1; this is the journal's own figure, as LetPub lists none for it; CiteScore 3.5, h-index 54.
How long does peer review take at Journal of Pharmacy Practice?
The publisher reports about 162 days (submission to acceptance); the journal's website gives an acceptance rate of 11.8%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Journal of Pharmacy Practice based?
Of the 68 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (65), United Kingdom (2) and Saudi Arabia (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Pharmacy Practice?
According to LetPub and DOAJ records, Journal of Pharmacy Practice is indexed in ESCI and Scopus. The journal's website also lists MEDLINE and Embase; that list has not been checked against each database.
Is Journal of Pharmacy Practice open access, and what is the APC?
Journal of Pharmacy Practice is a hybrid journal. For open-access publication: APC about USD 4,150.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .